A Study of RAY1225 Versus Semaglutide as Add-on Therapy to Oral Antidiabetic Drugs in Participants With Type 2 Diabetes
NCT07139548 · Status: NOT_YET_RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 600
Last updated 2025-08-24
Summary
The reason for this study is to compare the effect of the study drug RAY1225 to semaglutide on blood sugar levels in participants with type 2 diabetes.
Conditions
- T2DM
Interventions
- DRUG
-
RAY1225
Administered SC
- DRUG
-
Administered SC
Sponsors & Collaborators
-
Guangdong Raynovent Biotech Co., Ltd
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-08-31
- Primary Completion
- 2026-12-01
- Completion
- 2026-12-31
Countries
- China
Study Locations
More Related Trials
-
A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide Compared With Insulin Degludec and Liraglutide in Healthy Chinese Subjects
NCT03292185 ·Status: COMPLETED ·Phase: PHASE1
-
Effect and Safety of Liraglutide 3.0 mg in Subjects With Overweight or Obesity and Type 2 Diabetes Mellitus Treated With Basal Insulin
NCT02963922 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Liraglutide in Combination With an OAD in Subjects With Type 2 Diabetes Insufficiently Controlled on OAD Alone
NCT01512108 ·Status: COMPLETED ·Phase: PHASE3
-
A Research Study of How the Medicine NNC0480-0389 Taken With Semaglutide Works in the Body of Healthy Chinese Men
NCT05498610 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate Safety, Tolerability and pK of Semaglutide ER Injectable Suspension in Healthy, Adult Human Subjects
NCT06422624 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Efficacy and Safety of Oral Semaglutide Versus Liraglutide and Versus Placebo in Subjects With Type 2 Diabetes Mellitus
NCT02863419 ·Status: COMPLETED ·Phase: PHASE3
-
A Pharmacokinetic Study Comparing the Liraglutide Injection (RD12014) and Victoza® in Healthy Chinese Subjects
NCT05294536 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Semaglutide Injection vs Ozempic® in Patients With Type 2 Diabetes
NCT06739044 ·Status: COMPLETED ·Phase: PHASE3
-
Dose-response, Safety and Efficacy of Oral Semaglutide Versus Placebo and Versus Liraglutide, All as Monotherapy in Japanese Subjects With Type 2 Diabetes
NCT03018028 ·Status: COMPLETED ·Phase: PHASE3
-
PEG-rhGH and Semaglutide Combination Therapy in Non-Diabetic Obese Adults
NCT06863363 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Efficacy and Safety of KAI-9531 Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
NCT07284979 ·Status: RECRUITING ·Phase: PHASE3
-
A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight for the Maintenance of Weight Loss
NCT04660643 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Efficacy and Safety of Semaglutide Injection in the Treatment of Type 2 Diabetes Mellitus
NCT05816057 ·Status: COMPLETED ·Phase: PHASE3
-
A Research Study of How NNC0174-0833 Taken With Semaglutide Works in People Who Are Overweight or Obese
NCT03600480 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic Similarity, Safety, and Immunogenicity of Semaglutide Injection and Ozempic ® Injection in Healthy Subjects.
NCT06634927 ·Status: COMPLETED ·Phase: PHASE1
-
A Research Study to Compare Two Different Forms of Once-weekly Semaglutide in Two Different Injection Pens
NCT04238962 ·Status: COMPLETED ·Phase: PHASE1
-
A Research Study to Compare Two Forms of Semaglutide in Two Different Pen-injectors in People With Overweight or Obesity
NCT04012255 ·Status: TERMINATED ·Phase: PHASE1
-
A Research Study to Investigate How Well NNC0165-1875 in Combination With Semaglutide Works in People With Obesity
NCT04969939 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase III Study Comparing the Weight Loss Effects of Semaglutide Injection and Wegovy®
NCT06633783 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
A Study of LY3298176 (Tirzepatide) For the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities
NCT06047548 ·Status: COMPLETED ·Phase: PHASE3
-
A Research Study to Look Into How Well Semaglutide Medicine Works at Different Doses in People With Type 2 Diabetes and Overweight
NCT05486065 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of TG103 Injection in Overweight or Obesity
NCT05299697 ·Status: UNKNOWN ·Phase: PHASE2
-
The Safety, Tolerability and Pharmacokinetic Study of RAY1225
NCT05835752 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of LY3549492 in Adults With Obesity or Overweight With Type 2 Diabetes
NCT07030868 ·Status: TERMINATED ·Phase: PHASE2
-
A Trial Investigating the Influence of Oral Semaglutide on the Pharmacokinetics of Levothyroxine and the Influence of Co-administered Tablets on the Pharmacokinetics of Semaglutide Administered Orally in Healthy Subjects.
NCT02920385 ·Status: COMPLETED ·Phase: PHASE1